- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02908009
A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery (Ob-Card)
November 9, 2023 updated by: University of Leicester
An Observational Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery
This is a prospective, single-centre case control comparison of expression of target genes responsible for energy utilisation, mitochondrial function and oxidative stress and levels of histone acetylation/ DNA methylation in obese and non-obese adult cardiac surgery patients.
The study aims to test several inter-related hypotheses in a consecutive sequence of patients undergoing coronary artery bypass grafting.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tracy Kumar
- Phone Number: 01162583039
- Email: tk98@leicester.ac.uk
Study Locations
-
-
Leicestershire
-
Glenfield, Leicestershire, United Kingdom, LE3 9QP
- Recruiting
- England
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
The study will be carried out at a large tertiary academic cardiac surgery unit in the UK; the University Hospitals of Leicester NHS Trust.
This unit performs over 1,200 major cardiac procedures per year, of which 600 are patients undergoing coronary artery bypass grafting
Description
Inclusion Criteria:
- Patients with pre-existing paroxysmal, persistent or chronic atrial fibrillation,
Exclusion Criteria:
- Patients with pre-existing inflammatory state: sepsis undergoing treatment, acute kidney injury within 5 days, chronic inflammatory disease, congestive heart failure.
- Emergency or salvage procedure.
- Ejection fraction <30 %.
- Patient in a critical preoperative state (Kidney Disease: Improving Global Outcomes (KDIGO) Stage 3 AKI [20] or requiring inotropes, ventilation or intra-aortic balloon pump).
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post surgery inotrope score
Time Frame: inotrope score measured up to 48 hours post-surgery
|
inotrope score measured up to 48 hours post-surgery
|
inotrope score measured up to 48 hours post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in expression of target genes
Time Frame: Collected at the time of surgery
|
from right atrial biopsies
|
Collected at the time of surgery
|
|
Changes in epigenetic regulation of target genes from left atrial biopsies.
Time Frame: Collected at the time of surgery
|
histone acetylation, DNA methylation
|
Collected at the time of surgery
|
|
Changes in mitochondrial function
Time Frame: before and after sugery (up to 12 hours post surgery)
|
in atrial biopsies and buffy coats of blood samples collected before and after surgery
|
before and after sugery (up to 12 hours post surgery)
|
|
Myocardial Injury
Time Frame: baseline and 24 hours
|
defined by post cardiac surgery serum Troponin levels
|
baseline and 24 hours
|
|
Acute kidney injury
Time Frame: baseline, and up to 15 days post surgery (discharge)
|
defined by serum creatinine level postoperatively, as per the KDIGO criteria
|
baseline, and up to 15 days post surgery (discharge)
|
|
Perioperative clinical characteristics
Time Frame: Collected pre op
|
Perioperative clinical characteristics
|
Collected pre op
|
|
Perioperative medications.
Time Frame: Collected pre op
|
Perioperative medications.
|
Collected pre op
|
|
Data to calculate Multiple Organ Dysfunction (MOD) score.
Time Frame: baseline, and up to 96 hours post surgery
|
To calculate the MOD score, the Respiratory Function (calculated as partial pressure of oxygen (PaO2) divided by fraction of inspired oxygen (FiO2)), Cardiovascular (Pressure adjusted heart rate (PAR) ), Renal (Serum Creatinine), Hepatic (serum bilirubi
|
baseline, and up to 96 hours post surgery
|
|
Data to capture Acute Respiratory Distress Syndrome (Berlin criteria ARDS).
Time Frame: baseline, and up to 96 hours post surgery
|
Acute Lung Injury (ALI) non-ARDS, ARDS.
To define these different categories of acute lung injury, the Positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) will be recorded in the CRF at time points: Pre-OP, ICU, 12 hrs post-op,24hrs post-op,48hrs post-op,72hrs post-op and 96hrs post-op.
Along with the PaO2/FiO2 ratio, it will then be possible to categorise patients into the above definitions of acute lung injury as follows: ALI non-ARDS (200 mmHg <PaO2/FiO2<300 mmHg, regardless of PEEP),ARDS (PaO2/FiO2<200 mmHg, regardless of PEEP), mild Berlin Definition(200mmHg <PaO2/FiO2<300mmHg with PEEP > 5cm H2O),moderate Berlin Definition(100mmHg <calculated as partial pressure of oxygen divided by fraction of inspired oxygen PaO2/FiO2 < 200mmHg with PEEP > 5cm H2O) and Severe Berlin Definition (PaO2/FiO2 < 100mmHg with PEEP > 5cm H2O)
|
baseline, and up to 96 hours post surgery
|
|
Data on demographics
Time Frame: Pre Op
|
Height in cms
|
Pre Op
|
|
Data on demographics
Time Frame: Pre Op
|
Weight in kgs
|
Pre Op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gavin Murphy, University of Leicester
- Principal Investigator: Filiberto Serraino, University of Leicester
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995 Oct;23(10):1638-52. doi: 10.1097/00003246-199510000-00007.
- Adebayo AS, Roman M, Zakkar M, Yusoff S, Gulston M, Joel-David L, Anthony B, Lai FY, Murgia A, Eagle-Hemming B, Sheikh S, Kumar T, Aujla H, Dott W, Griffin JL, Murphy GJ, Wozniak MJ. Gene and metabolite expression dependence on body mass index in human myocardium. Sci Rep. 2022 Jan 26;12(1):1425. doi: 10.1038/s41598-022-05562-8.
- ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 9, 2016
Primary Completion (Estimated)
October 7, 2024
Study Completion (Estimated)
October 7, 2024
Study Registration Dates
First Submitted
July 19, 2016
First Submitted That Met QC Criteria
September 15, 2016
First Posted (Estimated)
September 20, 2016
Study Record Updates
Last Update Posted (Estimated)
November 14, 2023
Last Update Submitted That Met QC Criteria
November 9, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0574
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on C.Surgical Procedure; Cardiac
-
Erasme University HospitalJean Paul Van VoorenTerminated
-
University Hospital, CaenCompletedHemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA) (EMOA)C.Surgical Procedure; CardiacFrance
-
University of Sao Paulo General HospitalInCor Heart Institute; Chinese Academy of Medical Sciences, Fuwai Hospital; Beneficência... and other collaboratorsUnknownC.Surgical Procedure; CardiacBrazil
-
Hongwen JiCompleted
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterCompletedC.Surgical Procedure; CardiacKorea, Republic of
-
Helsinki University Central HospitalCompleted
-
Unity Health TorontoUnknownC.Surgical Procedure; CardiacCanada
-
Arkansas Children's Hospital Research InstituteCompletedC.Surgical Procedure; CardiacUnited States
-
Instituto do CoracaoRecruitingC.Surgical Procedure; Cardiac | Heart; Dysfunction Postoperative, Cardiac SurgeryBrazil
-
IRCCS San Raffaele RomaEttore Sansavini Health Science FoundationCompletedC.Surgical Procedure; CardiacItaly